Physician

Asad Fraser, M.D.

According to 2025 Medicare claims, Asad Fraser, M.D. (NPI: 1497759286) practices rheumatology in the Bowling Green, KY market, with the plurality of this provider's patient population coming from Warren, KY. This provider's primary affiliated billing organization is GRAVES GILBERT CLINIC PLLC (NPI: 1114948288; TIN: 610700826) and primary practice location at 42101-4000. Fraser is affiliated with the Caravan Health ACO 50 LLC (ACO ID: A5160) and GGC ValueCare LLC (ACO ID: A5611), participating under the MSSP model.

Fraser's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 438 traditional Medicare patients, billed 28,362 HCPCS/CPT codes, and received $372,341 in Medicare payments. The top billing code was 86200 (Measurement of antibody for rheumatoid arthritis assessment). Part D data shows 1,755 prescription claims across 349 beneficiaries totaling $1,812,592 in drug costs, led by Xeljanz Xr (Tofacitinib Citrate). Open Payments data shows 228 records totaling $84,827. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $848,204 to $372,341. In contrast, Part D prescription costs have risen steadily, from $795,946 to $1,812,592. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	531	46,328	$848,204
2016	523	48,373	$927,018
2017	544	41,238	$843,394
2018	541	38,056	$786,318
2019	515	33,479	$633,803
2020	525	27,111	$525,848
2021	491	29,036	$492,184
2022	486	35,718	$468,524
2023	503	29,493	$406,719
2024	438	28,362	$372,341

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	382	2,734	$795,946
2016	410	2,952	$1,125,456
2017	406	3,094	$1,390,214
2018	412	2,760	$2,784,365
2019	373	2,101	$1,508,060
2020	356	2,060	$1,550,644
2021	336	1,882	$1,153,447
2022	397	2,294	$2,364,125
2023	385	1,848	$2,540,535
2024	349	1,755	$1,812,592

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
86200	Measurement of antibody for rheumatoid arthritis assessment	293	353	$13
82550	Creatine kinase (cardiac enzyme) level, total	336	417	$6
86140	Measurement c-reactive protein for detection of infection or inflammation	360	486	$5
84550	Uric acid level, blood	338	423	$4
85652	Red blood cell sedimentation rate, to detect inflammation, automated	360	474	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xeljanz Xr	Tofacitinib Citrate	18	660	$126,770
Xeljanz	Tofacitinib Citrate	18	540	$103,657
Rinvoq	Upadacitinib	11	330	$71,677
Otezla	Apremilast	13	390	$62,893
Tymlos	Abaloparatide	14	420	$37,338

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	227	$61,963	Amgen Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$22,864	Novartis Pharmaceuticals Corporation
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Asad Fraser, M.D.?

Tedicare shows public-source Medicare data for Asad Fraser, M.D. (NPI 1497759286), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Asad Fraser, M.D. have ACO affiliation data?

Asad Fraser, M.D. is shown with ACO affiliation data for Caravan Health ACO 50 LLC (MSSP, ACO ID A5160) and GGC ValueCare LLC (MSSP, ACO ID A5611).

What billing organization is linked to Asad Fraser, M.D.?

Asad Fraser, M.D. is linked to GRAVES GILBERT CLINIC PLLC (billing NPI 1114948288) in the available physician profile data.

Does Asad Fraser, M.D. have Open Payments data?

Asad Fraser, M.D. has 228 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.